Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Breast Cancer Uses Growth Factors to Lure Stem Cells

08.06.2005


Like a siren song, breast cancer secretes growth factors to attract stem cells then uses those cells – which normally promote healing – to help it survive, researchers have found.



In the laboratory, the researchers have documented secretion of growth factors FGF2 and VEGF by breast cancer cells, seen these factors bind to receptors on stem cells then watched stem cells migrate toward the cancer. When they took the growth factors away, the deadly migration decreased.

“These stem cells are there to make normal tissue; they make fat, cartilage, bone,” says Dr. Adam Perry, general surgery resident at the Medical College of Georgia. “But if you have a tumor, it will in a sense mimic some tissue type to get the cells to come and help form the environment that is called the tumor stroma that it needs to get beyond a certain size. That’s really when cancer becomes clinically problematic.”


Knowing how tumors attract the stem cells they need to thrive opens up new avenues for earlier detection, better staging and more targeted therapies, he says.

Dr. Perry’s work on this fatal attraction between cancer and adult bone marrow stem cells earned him the Peter J. Gingrass, M.D. Memorial Award for the best paper presented by a medical student or non-plastic surgery resident during the recent 50th anniversary meeting of the Plastic Surgery Research Council.

“When you have a growing tumor, the tumor cells cannot stand alone,” says Dr. Edmond Ritter, MCG plastic surgeon and senior co-investigator. “Tumors have specific colon cancer or breast cancer or melanoma cells, but they also have to have supporting framework which includes fibroblasts as well as blood vessels.”

Normally, FGF2 makes connective tissue and VEGF makes blood vessels. It was known that tumors contain these growth factors as well as others and that they utilize stem cells to help build the infrastructure they need. “We wanted to figure out what attracts these stem cells,” says Dr. Perry. “What makes them move?”

“You need blood vessels. You need other tissue that forms basically a home or a nest for the tumor,” says Dr. Erhard Bieberich, MCG biochemist and senior investigator. “Without that, you don’t get metastasis. Without the activity of those stem cells, metastasis would only grow to a particular size but it would not be life-threatening. But once the body response kicks in and accepts the metastasis as some sort of useful tissue, it really gets dangerous.”

The MCG researchers hypothesized that growth factors secreted by tumors cells might play a role in this acceptance.

Dr. Bao-Ling Adam, a cancer researcher and proteomics expert, helped measure levels of FGF2 and VEGF – both proteins – using a high-tech approach that enables evaluation of hundreds of proteins at one time.

Cells need protein to survive and cells normally keep some proteins they make and shed others, Dr. Adam says. Much as a blood test can show what proteins are being secreted in the body, the researchers looked in the cell culture media where the cancer cells resided to see what proteins were being secreted.

“We wanted to see what kind of molecules are released in the media and then what molecules attract stem cells,” says Dr. Adam. They are still working to identify other molecules that were secreted, but FGF2 and VEGF were definite standouts.

“In the case of breast cancer, FGF2 and VEGF meet the criteria as candidate molecules and we believe they have an important role but are not the only answer as to why stem cells migrate,” says Dr. Ritter, who specializes in reconstruction following mastectomy.

The researchers say different kinds of tumors likely send out different growth factors to lure stem cells. In fact, they’ve already shown that melanoma also uses VEGF but not FGF2. “You don’t want to treat every tumor alike,” says Dr. Ritter.

They believe knowing the factors that help lead stem cells astray is an important first step in stopping the deadly attraction. “The first generation of chemotherapy was more targeting the cell division of cancer,” says Dr. Bieberich. “Now we are entering a new phase where we are targeting more the communication pathways.” Possibilities include using antibodies or other small molecules to block growth factor receptors or even turning the tables on cancer by arming stem cells with a mechanism to kill the cancer once they connect, he says.

Dr. Perry has seen the need for options other than chemotherapy, radiation therapy or surgery in his relatively short professional life. “What we are doing now is looking at more precise, specific ways to treat cancer on cellular level. This requires an immense understanding of tumor biology and what is going on. We are trying to chip away at that puzzle.”

Dr. Perry is just completing a year of research in the laboratories of Drs. Bieberich and Adam. He plans to pursue a plastic surgery fellowship after completing his surgery residency.

A significant part of the initial work for these studies was conducted by Kathryn Tucciarone, who worked as a research assistant in Dr. Bieberich’s lab. Dr. Jack Yu, chief of the Section of Plastic and Reconstructive Surgery, and Dr. Thomas N. Wang, surgical oncologist, also supported the studies.

Toni Baker | EurekAlert!
Further information:
http://www.mcg.edu

More articles from Life Sciences:

nachricht Bacteria as pacemaker for the intestine
22.11.2017 | Christian-Albrechts-Universität zu Kiel

nachricht Researchers identify how bacterium survives in oxygen-poor environments
22.11.2017 | Columbia University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Nanoparticles help with malaria diagnosis – new rapid test in development

The WHO reports an estimated 429,000 malaria deaths each year. The disease mostly affects tropical and subtropical regions and in particular the African continent. The Fraunhofer Institute for Silicate Research ISC teamed up with the Fraunhofer Institute for Molecular Biology and Applied Ecology IME and the Institute of Tropical Medicine at the University of Tübingen for a new test method to detect malaria parasites in blood. The idea of the research project “NanoFRET” is to develop a highly sensitive and reliable rapid diagnostic test so that patient treatment can begin as early as possible.

Malaria is caused by parasites transmitted by mosquito bite. The most dangerous form of malaria is malaria tropica. Left untreated, it is fatal in most cases....

Im Focus: A “cosmic snake” reveals the structure of remote galaxies

The formation of stars in distant galaxies is still largely unexplored. For the first time, astron-omers at the University of Geneva have now been able to closely observe a star system six billion light-years away. In doing so, they are confirming earlier simulations made by the University of Zurich. One special effect is made possible by the multiple reflections of images that run through the cosmos like a snake.

Today, astronomers have a pretty accurate idea of how stars were formed in the recent cosmic past. But do these laws also apply to older galaxies? For around a...

Im Focus: Visual intelligence is not the same as IQ

Just because someone is smart and well-motivated doesn't mean he or she can learn the visual skills needed to excel at tasks like matching fingerprints, interpreting medical X-rays, keeping track of aircraft on radar displays or forensic face matching.

That is the implication of a new study which shows for the first time that there is a broad range of differences in people's visual ability and that these...

Im Focus: Novel Nano-CT device creates high-resolution 3D-X-rays of tiny velvet worm legs

Computer Tomography (CT) is a standard procedure in hospitals, but so far, the technology has not been suitable for imaging extremely small objects. In PNAS, a team from the Technical University of Munich (TUM) describes a Nano-CT device that creates three-dimensional x-ray images at resolutions up to 100 nanometers. The first test application: Together with colleagues from the University of Kassel and Helmholtz-Zentrum Geesthacht the researchers analyzed the locomotory system of a velvet worm.

During a CT analysis, the object under investigation is x-rayed and a detector measures the respective amount of radiation absorbed from various angles....

Im Focus: Researchers Develop Data Bus for Quantum Computer

The quantum world is fragile; error correction codes are needed to protect the information stored in a quantum object from the deteriorating effects of noise. Quantum physicists in Innsbruck have developed a protocol to pass quantum information between differently encoded building blocks of a future quantum computer, such as processors and memories. Scientists may use this protocol in the future to build a data bus for quantum computers. The researchers have published their work in the journal Nature Communications.

Future quantum computers will be able to solve problems where conventional computers fail today. We are still far away from any large-scale implementation,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Ecology Across Borders: International conference brings together 1,500 ecologists

15.11.2017 | Event News

Road into laboratory: Users discuss biaxial fatigue-testing for car and truck wheel

15.11.2017 | Event News

#Berlin5GWeek: The right network for Industry 4.0

30.10.2017 | Event News

 
Latest News

Corporate coworking as a driver of innovation

22.11.2017 | Business and Finance

PPPL scientists deliver new high-resolution diagnostic to national laser facility

22.11.2017 | Physics and Astronomy

Quantum optics allows us to abandon expensive lasers in spectroscopy

22.11.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>